PROSPER: A MULTINATIONAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER
PROSPER: A MULTINATIONAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER
The purpose of this study is to assess the safety and efficacy of enzalutamide in patients with non metastatic prostate cancer.
Inclusion Criteria:
Exclusion Criteria:
San Luis Obispo, California 93405, United States
New Haven, Connecticut 06510, United States
Nashville, Tennessee 37232, United States
Berazategui, Buenos Aires B1884BBF, Argentina
CABA, Buenos Aires C1019ABS, Argentina
CABA, Buenos Aires C1120AAT, Argentina
CABA, Buenos Aires C1199BB, Argentina
Porto Alegre, Rio Grande do Sul 90430-090, Brazil
Campinas, São Paulo 13083-970, Brazil
Santo André, São Paulo 09060-650, Brazil
Sao Paulp, São Paulo 05652-900, Brazil
London, Ontario N6A 4L6, Canada
London, Ontario N6A 5W9, Canada
Shanghai, Shanghai Municipality 200092, China
Hangzhou, Zhejiang 310009, China
Arhus N, 8200, Denmark
Bordeaux, 33076, France
Mannheim, Baden-Wurttemberg 68167, Germany
Braunschweig, Lower Saxony 38102, Germany
Pátrai, 26504, Greece
Cremona, 26100, Italy
Milan, 20133, Italy
Milan, 20141, Italy
Roma, 00152, Italy
Cheras, Kuala Lumpur 56000, Malaysia
Moscow, 115478, Russia
Moscow, 125284, Russia
Saint Petersburg, 194354, Russia
Saint Petersburg, 197002, Russia
Saint Petersburg, 197022, Russia
Saint Petersburg, 197183, Russia
Hwasun-gun, Jeollanam-do 58128, South Korea
Santiago de Compostela, A Coruna 15706, Spain
Chiayi County, 613, Taiwan
Kaohsiung City, 830, Taiwan
Keelung, 204, Taiwan
Taoyuan County, 333, Taiwan
Muang, Chiang Mai 50200, Thailand
Kyiv, 02125, Ukraine
Newcastle upon Tyne, TYNE and WEAR NE7 7DN, United Kingdom